Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Delay to roflumilast regulatory filing in U.S.

Nov. 2, 2004

Aridol asthma test meets endpoints in phase III study

Nov. 2, 2004

Approvable letter for Alvesco for persistent asthma

Oct. 29, 2004

Spiriva approved for Japanese import

Oct. 27, 2004

Positive phase II results for Corus-1020

Oct. 25, 2004

Novel prostanoid DP antagonists under study at Taisho

Oct. 21, 2004

Two series of chemokine CCR8 antagonists claimed by GSK researchers

Oct. 20, 2004

Positive in vivo report comparing MDI-P to tobramycin

Oct. 19, 2004

Theravance researchers claim dual beta2-AR agonists/muscarinic antagonists

Oct. 19, 2004

New xanthine-based adenosine A1 antagonists covered by Endacea patent

Oct. 15, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...